InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: JediMozart post# 12077

Tuesday, 03/15/2022 12:45:15 PM

Tuesday, March 15, 2022 12:45:15 PM

Post# of 13742
“We hope that those who follow our company see how quickly we are moving in this process since receiving our response from the FDA. These programs generally take years and we have wasted no time since receiving the guidelines in preparing for our next steps. We are extremely confident in Escozine’s potential palliative and therapeutic”
https://microcaps.com/press-release/medolife-rx-announces-successful-stability-results-on-escozine-conjugated-with-radioactive-iodine/

I should have added … that while yes, long arduous road “speed is relative” … by foot for example walking across the country would take a long time, by car less and by flight obviously significantly less time ..
.. so when you read quotes like “how quickly we are moving” … we need to understand quick is relative .. and clearly qnta is indicating “quickly” relative to others in their field
After decade(s) of research, relatively speaking in timelines IMO the way I see it we are (soon) seeing the pinnacle on the horizon… when reading the research and steps taken over the last decade(s) to where the company’s research is now …. the escozine research has continued to push forward with promising results … then Covid escozine use has promising results as well …
Waiting can be stressful… but it’s worth noting as more tests and data are requested and they continue to collect positive results it simply propels the company fwd … slowly but surely the tortoise won the race against the hare in the Children’s fable …
Slow and steady often proves a winning strategy in life too …

“This could have major applications across the spectrum of healthcare”
https://microcaps.com/press-release/medolife-rx-announces-successful-stability-results-on-escozine-conjugated-with-radioactive-iodine/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.